Description
🦠 ViroCure 800
Favipiravir 800mg Tablet: Oral Antiviral for Influenza and Emerging Viral Infections
What Is It?
Favipiravir 800mg Tablet is an oral antiviral medication used in the treatment of mild to moderate influenza and has been repurposed in some countries for managing COVID-19 and other viral infections under medical supervision. It inhibits viral replication, helping to control the spread of the virus in the body.
Ingredients & Mechanism of Action
-
Favipiravir (800 mg):
An antiviral agent that inhibits RNA-dependent RNA polymerase, an enzyme essential for the replication of RNA viruses. By interfering with viral RNA synthesis, Favipiravir prevents the virus from multiplying, reducing viral load and disease severity.
Uses
-
Approved for treating influenza (in certain countries)
-
Used off-label or under emergency use for COVID-19
-
Investigated for Ebola, Lassa fever, and other viral infections
Always use only under the guidance of a healthcare provider, especially outside of its approved indications.
How to Use
-
Dosage for adults (influenza/COVID-19):
-
Day 1: 1600 mg (2 tablets of 800 mg) twice daily
-
Days 2–5 (or up to 14 days): 600–800 mg twice daily (per protocol)
-
-
Administration:
Take tablets with water, preferably after food to reduce gastric discomfort. Do not crush or chew. -
Course duration:
Typically 5 to 14 days based on disease severity and physician’s advice.
Common Side Effects
-
Gastrointestinal issues:
Nausea, vomiting, diarrhea -
Elevated liver enzymes:
Mild and reversible in most cases -
Increased uric acid levels:
Can lead to gout or joint pain -
Headache or dizziness
These side effects are usually temporary and manageable with supportive care.
Serious Side Effects (Seek medical attention immediately)
-
Severe liver injury: Yellowing of skin/eyes, dark urine
-
Allergic reactions: Rash, swelling, breathing difficulty
-
Mood changes or confusion (rare neurological effects)
-
Severe hyperuricemia: Painful joints, especially in patients with gout history
Monitoring & Follow-Up
-
Liver function tests (LFTs): Baseline and during treatment
-
Uric acid levels: Especially in patients with history of gout
-
Pregnancy tests: Mandatory for women of childbearing age
-
Symptom tracking: Monitor fever, respiratory symptoms, and viral load if applicable
Warnings & Precautions
-
Pregnancy & breastfeeding: Contraindicated – known risk of fetal harm; women must use reliable contraception during and after treatment.
-
Renal or hepatic impairment: Use with caution; dose adjustments may be necessary.
-
Pediatric use: Safety not established for children.
-
Drug interactions: Avoid with immunosuppressants and hepatotoxic drugs unless advised.
Not to be used for prophylaxis unless under research protocols or regulatory guidance.
Summary
Favipiravir 800mg Tablet is a potent oral antiviral initially developed for influenza and now used under specific guidelines for viral infections like COVID-19. It works by stopping virus replication and can reduce symptom severity and recovery time. While generally well tolerated, it requires monitoring of liver function and uric acid, and strict avoidance in pregnancy. Its use should be strictly physician-guided, especially in off-label scenarios.
Note: This information is intended for educational purposes and should not replace professional medical advice. Always consult a healthcare provider for personalized guidance.
